BillionToOne, Inc. Class A Common Stock vs. CareDx, Inc.
CareDx, Inc. (CDNA) comes out ahead, leading on 7 of 9 compared factors.
Size & Scale
| BLLN | CDNA | |
|---|---|---|
| Market Cap | $4.32 billion | $2.32 billion |
| Revenue (TTM) | $397.41 million | $458.09 million |
| Net Income (TTM) | $37.71 million | $111.01 million |
CDNA leads on 2 of 3 size & scale factors.
Valuation
| BLLN | CDNA | |
|---|---|---|
| P/E Ratio | 88.98 | 21.54 |
| Price / Book | 8.06 | 5.45 |
| Price / Sales | 10.88 | 5.06 |
CDNA leads on 3 of 3 valuation factors.
Profitability
| BLLN | CDNA | |
|---|---|---|
| Net Margin | 9.49% | 24.23% |
| Return on Equity | 7.03% | 26.08% |
CDNA leads on 2 of 2 profitability factors.
Risk & Sentiment
| BLLN | CDNA | |
|---|---|---|
| Short Interest | 0.13% | 7.55% |
BLLN leads on 1 of 1 risk & sentiment factors.
Dig deeper: BLLN overview, BLLN financials, CDNA overview, CDNA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
